📰 Medication Guide News
Page 45 - Medication Guide News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Medication Guide. Real-time updates on events, politics, business and more.
January 28, 2022
/PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Incyte (NASDAQ:INCY) today announced updates on the Phase 3 development program for OLUMIANT®...
January 28, 2022
INDIANAPOLIS, Jan. 28, 2022 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Incyte (NASDAQ:INCY) today announced updates on the Phase 3 deve...
January 27, 2022
KEYTRUDA Is Now Approved as Monotherapy for Adults With RCC at Increased Risk of Recurrence Following Nephrectomy, or Following Nephrectomy and Resection of Metastatic Lesions KEYTRUDA Is the First
January 27, 2022
/PRNewswire/ -- Indivior PLC (LON: INDV) today announced the publication of data from a clinical pharmacology study designed to assess the ability of...
January 27, 2022
/PRNewswire/ -- Indivior PLC (LON: INDV) today announced the publication of data from a clinical pharmacology study designed to assess the ability of...
January 26, 2022
A few important things to know about a different pill for ulcerative colitis.
January 24, 2022
IRVINE, Calif., Jan. 24, 2022 /PRNewswire/ -- Allergan Aesthetics, an AbbVie company (NYSE: ABBV) announced today it will be hosting an open casti...
January 21, 2022
/PRNewswire/ -- AbbVie (NYSE: ABBV) today announced the U.S. Food and Drug Administration (FDA) has approved SKYRIZI® (risankizumab-rzaa) for the treatment of...
January 21, 2022
/PRNewswire/ -- AbbVie (NYSE: ABBV) today announced the U.S. Food and Drug Administration (FDA) has approved SKYRIZI® (risankizumab-rzaa) for the treatment of...
January 20, 2022
/PRNewswire/ -- As reported in the Lancet Neurology, daridorexant is the first insomnia medication to demonstrate an effect of a drug therapy to improve both...